Steve Brozak is president of WBB Securities, LLC, an independent broker-dealer and investment bank specializing in biotechnology, medical devices and pharmaceutical research.

FORBES

In a note to investors, Stephen Brozak, an analyst at WBB Capital who has covered Geron on-and-off longer than perhaps any other analyst, wrote that the deal could be "potentially the validation" of the telomerase vaccine technology.

FORBES